Valerion Therapeutics is a biotechnology company focused on the development of bio-therapeutics for orphan genetic diseases. It utilizes a proprietary cell-penetrating antibody technology to target the cytoplasm of affected tissues. The company builds a platform that can be conjugated to proteins, small molecules, and oligonucleotides providing a pathway to treat various diseases.